发明公开
- 专利标题： ANTICANCER AGENT
- 专利标题（中）： 抗癌剂
-
申请号： EP13767892.6申请日： 2013-03-26
-
公开(公告)号： EP2832355A1公开(公告)日： 2015-02-04
- 发明人: ESUMI Hiroyasu , IKEDA Masafumi , MIYOSHI Chika , KADOTA Shigetoshi , OKUBO Toshiki , YOMODA Satoshi , FUSE Takafumi , KAWASHIMA Takanori , CHIBA Shigeki
- 申请人： Kracie Pharma, Ltd. , National Cancer Center , National University Corporation University of Toyama
- 申请人地址： 20-20, Kaigan 3-chome, Minato-ku Tokyo 1088080 JP
- 专利权人： Kracie Pharma, Ltd.,National Cancer Center,National University Corporation University of Toyama
- 当前专利权人： Kracie Pharma, Ltd.,National Cancer Center,National University Corporation University of Toyama
- 当前专利权人地址： 20-20, Kaigan 3-chome, Minato-ku Tokyo 1088080 JP
- 代理机构： Schön, Christoph
- 优先权： JP2012069964 20120326
- 国际公布： WO2013146734 20131003
- 主分类号： A61K31/341
- IPC分类号： A61K31/341 ; A61K31/7034 ; A61K36/00 ; A61K36/28 ; A61P35/00
摘要：
The present invention is intended to provide a novel anticancer agent which is effective to a cancer. After administering an agent prepared using burdock fruit extract to a pancreas cancer patient so that a dose of arctigenin was 100 mg or more per day, the tumor reducing effect was observed, and, in addition, lowering of tumor markers was confirmed. The present invention provides an anticancer agent containing arctigenin, wherein a dose of the arctigenin is 100 mg or more per day. In addition, the present invention provides the anticancer agent containing arctigenin and arctiin at a weight ratio of arctigenin/arctiin = 0.7 to 1.3.
信息查询
